Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Phase IIa study of PA-457 in HIV patients

Dec. 14, 2004

Launch of Fuzeon Accelerated Simultaneous Access Program

Dec. 7, 2004

Good safety profile reported for C31G vaginal gel in healthy volunteers

Dec. 1, 2004

Positive preliminary results from phase I/II study of PA-457

Nov. 25, 2004

Enrollment completed in phase II lipodystrophy study of EG-005

Nov. 25, 2004

Long-term antiviral activity of TMC-125 seen in HIV-infected patients

Nov. 24, 2004

TMC-114 active against resistant HIV-1

Nov. 24, 2004

Pharmacokinetic interactions with UK-427857 studied

Nov. 24, 2004

Positive opinion for Truvada in Europe

Nov. 22, 2004

VivaGel well tolerated in phase I study

Nov. 19, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...